Topshelf Finance USD Price & Performance (LIQRUSD)

Scienture Holdings has secured FDA approval for Arbli™, the first ready-to-use oral liquid losartan in the U.S. market. Targeting hypertension and related conditions, its commercial launch is set for Q3 2025. To fund this milestone, the company utilized its Equity Line of Credit while pausing further draws temporarily.1

The Russian stock market saw modest gains, with the Moscow Exchange and RTS indices rising 0.5%. Investors are optimistic ahead of a crucial Biden-Putin discussion on Ukraine. While oil prices climbed, mixed global market dynamics tempered broader enthusiasm. The talks could significantly impact investor sentiment in the coming days.2

Enphase Energy’s stock slid 8.2% following bearish sentiment in the options market. Despite launching its IQ EV Charger 2 in Europe, concerns about the company’s earnings report and broader economic conditions weighed heavily. Analysts remain cautious, reflecting uncertainties in the renewable energy sector.3